Recludix Pharma to Present at the Guggenheim Healthcare Talks Oncology Conference
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in platform approaches…
News
Bolt Biotherapeutics to Present at February Investor Conferences
REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Bolt Biotherapeutics to Present at February Investor Conferences
REDWOOD CITY, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program
Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing…
Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program
Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing…
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and…
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and…
Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day
NEEDHAM, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical…
Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day
NEEDHAM, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical…
Erasca to Present at the Guggenheim Oncology Conference 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
Erasca to Present at the Guggenheim Oncology Conference 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
Cogent Biosciences Announces Participation at Upcoming Investor Conferences
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Cogent Biosciences Announces Participation at Upcoming Investor Conferences
WALTHAM, Mass. and BOULDER, Colo., Feb. 01, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Galecto to Participate in SVB Securities Global Biopharma Conference
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Galecto to Participate in SVB Securities Global Biopharma Conference
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Ocugen Appoints Quan A. Vu as Chief Business Officer
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Ocugen Appoints Quan A. Vu as Chief Business Officer
MALVERN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer
Company plans to report interim data for the combination of UpRi with carboplatin in the second…